They found a half-life of under 30 minutes post-injection, with bioavailability after intramuscular administration at 14 to 19 percent for rats and 45 to 51 percent for dogs
It helps improve physical performance, supports muscle function, and may reduce tiredness and weakness
Indication-specific labeling reinforces this divergence
This approach ensures that GLP-1 treatment is both safe and effective based on individual needs, taking into account other factors such as medical conditions, medications, and possible side effects
Clinicians should evaluate for contraindications specific to GLP-1 receptor agonists, including: Personal or family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 History of pancreatitis or gallbladder disease Severe gastroparesis or gastrointestinal disease History of suicidal ideation or behavior Pregnancy or planned pregnancy (pregnancy testing when appropriate) Diabetic retinopathy (requires monitoring in patients with diabetes) Baseline investigations should include TSH, free T4, complete metabolic panel, lipid profile, and hemoglobin A1c (if diabetic or prediabetic)
Which GLP-1 has the least side effects when used for weight loss